This week's Fierce Pharma is brought to you by NeoGenomics.

Complimentary Whitepaper Download -- Hi E, check out this Fierce Whitepaper we think you'll like:

The Emergence of Multi-modal Real-world data

This resource will explore:

• Why biomarker and genomic data matters
• How these data sources unlock what’s been missing from traditional RWD sources
• How newly created longitudinal data sets support drug development from discovery to trial to post-market
• Why longitudinal data matters for developing targeted treatments for rare or complex conditions such as multiple myeloma
• How tokenization allows for better integration of disparate data sources and meets the scrutiny of peer review and regulatory approval